Friday, Dec 29, 2023 · SEC filings
What the smart money revealed on Dec 29
278 insider filings came in. We hid 54 planned (10b5-1) sellers and 139 people whose filings were routine, like grants and tax withholding.
Innsuites Hospitality Trust (IHT) President and CEO James Wirth bought $3.38M
1,500 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
HighPeak Energy (HPK) CEO Jack Hightower bought $2.42M
164,030 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Athira Pharma (LONA) Director Joseph Edelman bought $1.46M
605,686 shares on the open market. Not a grant or an option exercise.
Globalstar (GSAT) Director James Lynch bought $865K
500,000 shares on the open market. Not a grant or an option exercise.
Alpine Immune Sciences (ALPN) Director Peter Thompson sold $28.7M
Not marked as a planned 10b5-1 sale. Sold 38% of the shares they held directly. Still holds 2.54M shares.
Airbnb (ABNB) Director Joseph Gebbia sold $22.8M
Not marked as a planned 10b5-1 sale. Sold 100% of the shares they held directly. Still holds 21 shares.
Atlassian (TEAM) Co-CEO Michael Cannon-Brookes sold $3.95M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 16 more real buys
Show 40 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 23–29
Open-market buys by officers and directors, filed in the 7 days up to Dec 29.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.